Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Spontaneous splenic rupture in a patient with light-chain deposition disease undergoing autologous peripheral blood stem cell transplantation.

Haji S, Kiyasu J, Tachikawa Y, Toyonaga J, Ikeda M, Tsuda M, Tsukamoto Y, Kozuru M, Yufu Y.

Rinsho Ketsueki. 2016 Jun;57(6):754-9. doi: 10.11406/rinketsu.57.754. Review. Japanese.

PMID:
27384856
2.

[Infected abdominal aortic aneurysm from Campylobacter fetus bacteremia].

Yano K, Saito T, Yoshino S, Imura H, Kozuru M, Iwai T, Uchida T.

Nihon Naika Gakkai Zasshi. 2008 Jul 10;97(7):1675-7. Japanese. No abstract available.

PMID:
18681158
3.

Two novel mutations, L490R and V561X, of the transferrin receptor 2 gene in Japanese patients with hemochromatosis.

Koyama C, Wakusawa S, Hayashi H, Suzuki R, Yano M, Yoshioka K, Kozuru M, Takayamam Y, Okada T, Mabuchi H.

Haematologica. 2005 Mar;90(3):302-7.

4.

[Infective endocarditis due to HACEK group bacteria].

Nakamura K, Baba S, Doi R, Imura H, Kozuru M.

Nihon Naika Gakkai Zasshi. 2003 Aug 10;92(8):1521-3. Japanese. No abstract available.

PMID:
13677901
5.

Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).

Tsukasaki K, Tobinai K, Shimoyama M, Kozuru M, Uike N, Yamada Y, Tomonaga M, Araki K, Kasai M, Takatsuki K, Tara M, Mikuni C, Hotta T; Lymphoma Study Group of the Japan Clinical Oncology Group.

Int J Hematol. 2003 Feb;77(2):164-70.

PMID:
12627852
6.

A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M, Sano M, Ikeda S, Takatsuki K, Kozuru M, Araki K, Kawano F, Niimi M, Tobinai K, Hotta T, Shimoyama M.

Br J Haematol. 2001 May;113(2):375-82.

PMID:
11380402
7.

Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncology Group.

Takenaka T, Mikuni C, Miura A, Sasaki T, Suzuki H, Hotta T, Hirano M, Fukuhara S, Sugiyama H, Nasu K, Dohi H, Kozuru M, Tomonaga M, Tajima K, Niimi M, Fukuda H, Mukai K, Shimoyama M.

Jpn J Clin Oncol. 2000 Mar;30(3):146-52.

PMID:
10798542
8.

Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group.

Kobayashi T, Tobinai K, Shimoyama M, Mikuni C, Konda S, Kozuru M, Araki K, Sai T, Fukuhara S, Matsumoto M, Aoki I, Deura K, Oyama A, Hotta T, Abe T, Toki H, Nagai M, Fukuda H, Niimi M, Yamaguchi N, Tajima K, Shirakawa S.

Jpn J Clin Oncol. 1999 Jul;29(7):340-8.

PMID:
10470659
9.

Telomerase activity in myeloma cells is closely related to cell cycle status, but not to apoptotic signals induced by interferon-alpha.

Shiratsuchi M, Muta K, Umemura T, Nishimura J, Nawata H, Kozuru M.

Leuk Lymphoma. 1999 Jul;34(3-4):349-59.

PMID:
10439372
10.

[Detection of t(3 ; 21) (q26 ; q22) with AML1/EVI1 mRNA during progression of myelodysplastic syndrome to acute myeloid leukemia].

Choi I, Goto T, Nagano M, Muta K, Yufu Y, Uike N, Kozuru M, Abe Y, Nisimura J.

Rinsho Ketsueki. 1999 Jun;40(6):518-20. Japanese.

PMID:
10422292
11.

A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.

Yufu Y, Goto T, Choi I, Uike N, Kozuru M, Ohshima K, Taniguchi T, Motokura T, Yatabe Y, Nakamura S.

Cancer. 1999 Apr 15;85(8):1750-7.

PMID:
10223569
12.

Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias.

Nakayama M, Wada M, Harada T, Nagayama J, Kusaba H, Ohshima K, Kozuru M, Komatsu H, Ueda R, Kuwano M.

Blood. 1998 Dec 1;92(11):4296-307.

13.

Successful treatment of a patient with cardiac lymphoma who presented with a complete atrioventricular block.

Nagano M, Uike N, Suzumiya J, Muta K, Goto T, Suehiro Y, Choi I, Yufu Y, Taniguchi J, Kikuchi M, Kozuru M.

Am J Hematol. 1998 Oct;59(2):171-4.

14.

Soluble Fas in the serum of patients with non-Hodgkin's lymphoma: higher concentrations in angioimmunoblastic T-cell lymphoma.

Yufu Y, Choi I, Hirase N, Tokoro A, Noguchi Y, Goto T, Uike N, Kozuru M.

Am J Hematol. 1998 Aug;58(4):334-6.

15.

Adult T-cell leukemia-lymphoma successfully treated with 2-chlorodeoxyadenosine.

Uike N, Choi I, Tokoro A, Goto T, Yufu Y, Kozuru M, Tobinai K.

Intern Med. 1998 Apr;37(4):411-3.

16.

T-stem cell leukemia/lymphoma with both myeloid lineage conversion and T-specific delta recombination.

Nagano M, Kimura N, Akiyoshi T, Nishimura J, Kozuru M, Okamura J, Katsuno M, Yoshida T, Takeshita M, Tachibana K, Ohshima K, Kikuchi M.

Leuk Res. 1997 Aug;21(8):763-73.

PMID:
9379684
17.

Therapy-related acute myeloid leukemia with minimal myeloid differentiation (AML-M0) associated with a t(11;19)(q23;p13.3) translocation.

Suehiro Y, Uike N, Kumagawa M, Goto T, Muta K, Kozuru M.

Am J Hematol. 1997 Jul;55(3):165-6. No abstract available.

19.

Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.

Tobinai K, Ogura M, Hotta T, Kobayashi Y, Narabayashi M, Suzuki R, Kinoshita T, Kozuru M, Uike N, Ohashi Y.

Jpn J Clin Oncol. 1997 Jun;27(3):146-53.

PMID:
9255268
20.

[Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders].

Sawae Y, Niho Y, Okamura T, Gondo H, Kozuru M, Uike N, Muta K, Goto T, Suehiro Y, Kumakawa M, Nishimura J, Yufu Y, Ishikura H, Yamashita S, Hisano S, Morioka E, Nakajima H, Shibuya T, Yamasaki K, Harada N, Asayama R, Hayashi S, Akashi K, Suematsu E, Kawasaki C, et al.

Jpn J Antibiot. 1996 Dec;49(12):1049-61. Japanese.

PMID:
9032592
21.

High occurrence of primary malignant neoplasms in patients with adult T-cell leukemia/lymphoma, their siblings, and their mothers.

Kozuru M, Uike N, Muta K, Goto T, Suehiro Y, Nagano M.

Cancer. 1996 Sep 1;78(5):1119-24.

PMID:
8780552
22.

[Ineffective erythropoiesis and apoptosis].

Muta K, Kozuru M, Uike N.

Rinsho Ketsueki. 1996 Jul;37(7):531-5. Japanese. No abstract available.

PMID:
8779767
23.

High prevalence of T cell receptor D delta 2(D delta)J delta rearrangement in CD7-positive early T cell acute lymphoblastic leukemia.

Kimura N, Akiyoshi T, Uchida T, Okamura J, Kozuru M, Nishimura J, Ohyashiki JH, Kikuchi M, Niho Y, Okumura M.

Leukemia. 1996 Apr;10(4):650-7.

PMID:
8618442
24.

AILD-like dysplasia transformed in AILD-type T cell lymphoma in an HTLV-1 carrier: usefulness of interferon-alpha.

Kozuru M, Hashimoto M, Takahira H, Uike N, Ohoshima K, Takeshita M, Kikuchi M.

Acta Haematol. 1996;96(2):92-8.

PMID:
8701708
25.

Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma.

Ohshima K, Takeo H, Kikuchi M, Kozuru M, Uike N, Masuda Y, Yoneda S, Takeshita M, Shibata T, Akamatsu M.

Histopathology. 1994 Dec;25(6):569-79.

PMID:
7698734
26.

[A comparative study of imipenem/cilastatin sodium BID vs QID in the treatment of infections associated with hematopoietic disorders].

Sawae Y, Niho Y, Okamura T, Murakawa M, Teshima T, Fujisaki T, Ikeda K, Kozuru M, Uike N, Katsuno M, et al.

Jpn J Antibiot. 1994 Oct;47(10):1318-28. Japanese.

PMID:
7807693
27.

Gene expression of erythropoietin in hepatocellular carcinoma.

Muta H, Funakoshi A, Baba T, Uike N, Wakasugi H, Kozuru M, Jimi A.

Intern Med. 1994 Jul;33(7):427-31.

28.

Expression of adult and fetal natural killer cell markers in sinonasal lymphomas.

Suzumiya J, Takeshita M, Kimura N, Kikuchi M, Uchida T, Hisano S, Eura Y, Kozuru M, Nomura Y, Tomita K, et al.

Blood. 1994 Apr 15;83(8):2255-60.

29.

Establishment of a human myeloma cell line with growth-promoting activity for bone marrow-derived fibroblastoid colony-forming cells.

Takahira H, Kozuru M, Hirata J, Obama K, Uike N, Iguchi H, Miyamura T, Yamashita S, Kono A, Umemura T.

Exp Hematol. 1994 Mar;22(3):261-6.

PMID:
8112425
30.

Genetic changes in atypical hyperplasia and lymphoma with angioimmunoblastic lymphadenopathy and dysproteinaemia in the same patients.

Ohshima K, Kikuchi M, Hashimoto M, Kozuru M, Uike N, Kobari S, Masuda Y, Sumiyoshi Y, Yoneda S, Takeshita M, et al.

Virchows Arch. 1994;425(1):25-32.

PMID:
7921409
31.

[A case of primary non-Hodgkin lymphoma of the adrenal gland presenting with Addison's disease].

Miyamura T, Obama K, Takahira H, Uike N, Kozuru M.

Rinsho Ketsueki. 1993 Jul;34(7):882-4. Japanese.

PMID:
8360994
32.

[Report of two cases presenting with myelodysplastic syndrome during treatment of recurrent breast cancer].

Tashiro H, Nomura Y, Hisamatsu K, Baba M, Kozuru M, Uike N.

Gan To Kagaku Ryoho. 1993 Jul;20(9):1245-8. Japanese.

PMID:
8333753
33.

Parvovirus B19-associated haemophagocytosis in Evans syndrome: aplastic crisis accompanied by severe thrombocytopenia.

Uike N, Miyamura T, Obama K, Takahira H, Sato H, Kozuru M.

Br J Haematol. 1993 Jul;84(3):530-2.

PMID:
8217805
34.

Clinicopathologic, enzyme and histochemical studies of centrocytic (mantle cell) lymphoma: comparison with other types of low-grade B cell lymphoma based on the updated Kiel classification.

Takeshita M, Masuda Y, Sumiyoshi Y, Ohshima K, Kikuchi M, Kimura N, Okamura T, Nishimura J, Kozuru M.

Acta Pathol Jpn. 1993 May;43(5):244-52.

PMID:
8322610
35.

Phase I study of YK-176 (2'-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF Study Group.

Tobinai K, Shimoyama M, Inoue S, Takayasu S, Mikuni C, Kozuru M, Oda S, Nakajima H.

Jpn J Clin Oncol. 1992 Jun;22(3):164-71.

PMID:
1518164
36.

[i(17q) appearing in acute phase in Ph1-negative, BCR-negative CML].

Uike N, Yamashita S, Obama K, Takahira H, Nakai H, Inazawa J, Umemura T, Akashi K, Kozuru M.

Rinsho Ketsueki. 1992 May;33(5):694-9. Japanese.

PMID:
1630023
37.

[Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases].

Sawae Y, Niho Y, Harada M, Shibuya T, Okamura T, Asano Y, Taniguchi S, Murakawa M, Toyoshima T, Kozuru M, et al.

Jpn J Antibiot. 1992 Feb;45(2):123-35. Japanese.

PMID:
1613965
38.

Missing Y chromosome in Ph1-negative chronic myeloid leukemia with bcr rearrangement. Evidence for a bcr-abl recombination on chromosome 22 by in situ hybridization.

Uike N, Inazawa J, Nishigaki H, Takahira H, Katsuno M, Hashimoto M, Kozuru M.

Acta Haematol. 1991;85(1):51-5.

PMID:
2011934
39.

Genotypic and cytogenetic study of acute myelocytic leukemia and chronic myelocytic leukemia in blast crisis: specific delta rearrangement pattern does not involve J delta gene locus.

Akiyoshi TT, Kimura N, Uike N, Kozuru M, Tamura K, Takihara Y, Hisano S, Nishimura J, Kikuchi M.

Leuk Res. 1991;15(8):683-91.

PMID:
1654480
40.

Malignant lymphoma antigen expressed in nude mouse tumor cells derived from carcinogen-transformed Bloom's syndrome B-lymphoblastoid cell lines.

Shiraishi Y, Moriki T, Hara H, Araki K, Kozuru M, Sandberg AA.

Cancer Res. 1990 May 15;50(10):3106-12.

41.

The Differences between Lymphoma and Leukemia Type of Adult T-cell Leukemia.

Shimamoto Y, Yamaguchi M, Miyamoto Y, Yamaguchi J, Kuribayashi N, Sato H, Nishimura J, Nawata H, Kozuru M, Shimoyama M.

Leuk Lymphoma. 1990;1(2):101-12. doi: 10.3109/10428199009042466.

PMID:
27463815
42.

Anti-human T-cell lymphotrophic virus type I antibody-positive adult T-cell leukemia/lymphoma with no monoclonal proviral DNA. A clinicopathologic and immunologic study.

Yoshida T, Kikuchi M, Ooshima K, Takeshita M, Kimura N, Kozuru M, Satoh H.

Cancer. 1989 Dec 15;64(12):2515-24.

PMID:
2819660
43.

Rearrangement of T-cell receptor delta chain gene as a marker of lineage and clonality in T-cell lymphoproliferative disorders.

Kimura N, Takihara Y, Akiyoshi T, Yoshida T, Ohshima K, Kawara T, Hisano S, Kozuru M, Okumura M, Kikuchi M.

Cancer Res. 1989 Aug 15;49(16):4488-92.

44.

The possible mode of escape of adult T-cell leukaemia cells from antibody-dependent cellular cytotoxicity.

Kozuru M, Uike N, Takeichi N, Nakagawa S, Takahira H, Shibata K, Sato H.

Br J Haematol. 1989 Aug;72(4):502-6.

PMID:
2624625
45.

[Impaired superoxide production by neutrophils in myelodysplastic syndrome: correlation with bone marrow karyotype].

Uike N, Hashimoto M, Takeichi N, Kozuru M.

Rinsho Ketsueki. 1989 Jun;30(6):830-4. Japanese.

PMID:
2552193
46.

Dual rearrangement of immunoglobulin and T-cell receptor genes in blast crisis of CML.

Uike N, Takeichi N, Kimura N, Takahira H, Kozuru M.

Eur J Haematol. 1989 May;42(5):460-5.

PMID:
2543592
47.

[Ph1-positive chronic myelocytic leukemia developing promyelocytic acute crisis with addition of isochromosome (17q), report of two cases].

Shibata K, Uike N, Takeichi N, Akiyoshi T, Takahira H, Kozuru M.

Rinsho Ketsueki. 1988 Dec;29(12):2335-42. Japanese. No abstract available.

PMID:
3246719
48.

[Phenotypic analysis of acute megakaryoblastic leukemia following myelodysplastic syndrome. Evidence for leukemic cells reacting with 3A1 (CD7) and A2B5 monoclonal antibodies].

Uike N, Kozuru M, Takeichi N, Shibata K, Akiyoshi T, Anami K, Shibuya T, Niho Y, Oku K, Takeshita M, et al.

Rinsho Ketsueki. 1988 Jun;29(6):889-95. Japanese. No abstract available.

PMID:
3166500
49.

Regulation of erythropoietin and burst-promoting activity production in patients with aplastic anemia and iron deficiency anemia.

Takeichi N, Umemura T, Nishimura J, Motomura S, Kozuru M, Ibayashi H.

Acta Haematol. 1988;80(3):145-52.

PMID:
3143213
50.

[Myelodysplastic syndrome with monoclonal gammopathy characterized by plasmacytic infiltration to multiple organs in the terminal stage: report of an autopsy case].

Uike N, Kozuru M, Takeichi N, Shibata K, Hayashi I, Takeshita M, Kikuchi M.

Rinsho Ketsueki. 1987 Dec;28(12):2153-60. Japanese. No abstract available.

PMID:
3452658

Supplemental Content

Loading ...
Support Center